178 related articles for article (PubMed ID: 33513477)
1. Nasogastric tube feeding after transoral robotic surgery for oropharynx carcinoma.
Plonowska KA; Ochoa E; Zebolsky AL; Patel N; Hoppe KR; Ha PK; Heaton CM; Ryan WR
Am J Otolaryngol; 2021; 42(3):102857. PubMed ID: 33513477
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for gastrostomy tube dependence in transoral robotic surgery patients.
Philips R; Topf MC; Vimawala S; Luginbuhl A; Curry JM; Cognetti DM
Am J Otolaryngol; 2022; 43(1):103175. PubMed ID: 34418824
[TBL] [Abstract][Full Text] [Related]
3. Transoral robotic surgery versus nonrobotic resection of oropharyngeal squamous cell carcinoma.
Chillakuru Y; Benito DA; Strum D; Mehta V; Saini P; Shim T; Darwish C; Joshi AS; Thakkar P; Goodman JF
Head Neck; 2021 Jul; 43(7):2259-2273. PubMed ID: 33899949
[TBL] [Abstract][Full Text] [Related]
4. Functional outcomes, feasibility, and safety of resection of transoral robotic surgery: single-institution series of 35 consecutive cases of transoral robotic surgery for oropharyngeal squamous cell carcinoma.
Lörincz BB; Möckelmann N; Busch CJ; Knecht R
Head Neck; 2015 Nov; 37(11):1618-24. PubMed ID: 24955923
[TBL] [Abstract][Full Text] [Related]
5. Feeding Tube Placement Following Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma.
Feng AL; Holcomb AJ; Abt NB; Mokhtari TE; Suresh K; McHugh CI; Parikh AS; Holman A; Kammer RE; Goldsmith TA; Faden DL; Deschler DG; Varvares MA; Lin DT; Richmon JD
Otolaryngol Head Neck Surg; 2022 Apr; 166(4):696-703. PubMed ID: 34154449
[TBL] [Abstract][Full Text] [Related]
6. A Phase 2 Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed After Transoral Robotic Surgery for Human Papilloma Virus-Related Squamous Cell Carcinoma of the Oropharynx.
Swisher-McClure S; Lukens JN; Aggarwal C; Ahn P; Basu D; Bauml JM; Brody R; Chalian A; Cohen RB; Fotouhi-Ghiam A; Geiger G; Gershowitz J; Livolsi V; Mitra N; Montone K; Newman J; Ojerholm E; O'Malley B; Rajasekaran K; Tan E; Weinstein G; Lin A
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):725-732. PubMed ID: 31785337
[TBL] [Abstract][Full Text] [Related]
7. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ
Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038
[TBL] [Abstract][Full Text] [Related]
8. Decreased gastrostomy tube incidence and weight loss after transoral robotic surgery for low- to intermediate-risk oropharyngeal squamous cell carcinoma.
Heah H; Goepfert RP; Hutcheson KA; Garden AS; Gunn GB; Fuller CD; Lewin JS; Kupferman ME; Holsinger FC; Hessel AC; Gross ND
Head Neck; 2018 Nov; 40(11):2507-2513. PubMed ID: 30102824
[TBL] [Abstract][Full Text] [Related]
9. A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx.
Albergotti WG; Jordan J; Anthony K; Abberbock S; Wasserman-Wincko T; Kim S; Ferris RL; Duvvuri U
Cancer; 2017 Aug; 123(16):3132-3140. PubMed ID: 28467606
[TBL] [Abstract][Full Text] [Related]
10. Specimen-Based Resection Margins and Local Control during Transoral Robotic Surgery for Oropharyngeal HPV-Mediated Squamous Cell Carcinoma.
Magliocca KR; Kaka AS; Barrow EM; Studer MB; Griffith CC; Ernst J; Meade T; Balicki A; Boyce BJ; Schmitt NC; Bur AM; Schmitt AC; Jackson R; Steuer CE; Beitler JJ; Patel MR
ORL J Otorhinolaryngol Relat Spec; 2023; 85(2):80-87. PubMed ID: 36538901
[TBL] [Abstract][Full Text] [Related]
11. Positive Margins by Oropharyngeal Subsite in Transoral Robotic Surgery for T1/T2 Squamous Cell Carcinoma.
Persky MJ; Albergotti WG; Rath TJ; Kubik MW; Abberbock S; Geltzeiler M; Kim S; Duvvuri U; Ferris RL
Otolaryngol Head Neck Surg; 2018 Apr; 158(4):660-666. PubMed ID: 29182490
[TBL] [Abstract][Full Text] [Related]
12. Time course of subacute pain after transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma versus traditional bilateral tonsillectomy in adults - a case-control study.
Scott SI; Madsen AKØ; Rubek N; Channir HI; Kehlet H; von Buchwald C
Acta Otolaryngol; 2018 Sep; 138(9):837-842. PubMed ID: 29741427
[TBL] [Abstract][Full Text] [Related]
13. Oncological outcome following de-intensification of treatment for stage I and II HPV negative oropharyngeal cancers with transoral robotic surgery (TORS): A prospective trial.
Dabas S; Gupta K; Ranjan R; Sharma AK; Shukla H; Dinesh A
Oral Oncol; 2017 Jun; 69():80-83. PubMed ID: 28559025
[TBL] [Abstract][Full Text] [Related]
14. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.
Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C
Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651
[TBL] [Abstract][Full Text] [Related]
15. Adoption of transoral robotic surgery compared with other surgical modalities for treatment of oropharyngeal squamous cell carcinoma.
Cracchiolo JR; Roman BR; Kutler DI; Kuhel WI; Cohen MA
J Surg Oncol; 2016 Sep; 114(4):405-11. PubMed ID: 27392812
[TBL] [Abstract][Full Text] [Related]
16. Transoral robotic retropharyngeal node dissection in oropharyngeal squamous cell carcinoma: Patterns of metastasis and functional outcomes.
Troob S; Givi B; Hodgson M; Mowery A; Gross ND; Andersen PE; Clayburgh D
Head Neck; 2017 Oct; 39(10):1969-1975. PubMed ID: 28758272
[TBL] [Abstract][Full Text] [Related]
17. Management of Recurrent and Metastatic HPV-Positive Oropharyngeal Squamous Cell Carcinoma after Transoral Robotic Surgery.
Sims JR; Van Abel K; Martin EJ; Lohse CM; Price DL; Olsen KD; Moore EJ
Otolaryngol Head Neck Surg; 2017 Jul; 157(1):69-76. PubMed ID: 28374634
[TBL] [Abstract][Full Text] [Related]
18. Predictors of gastrostomy tube dependence in surgically managed oropharyngeal squamous cell carcinoma.
Varma VR; Eskander A; Kang SY; Kumar B; Brown NV; Zhao S; Brock G; Agrawal A; Carrau RL; Old MO; Ozer E; Rocco JW; Schuller DE; Dziegielewski PT; Cipolla MJ; Teknos TN
Laryngoscope; 2019 Feb; 129(2):415-421. PubMed ID: 30194767
[TBL] [Abstract][Full Text] [Related]
19. The Role of Transoral Robotic Surgery in the Management of HPV Negative Oropharyngeal Squamous Cell Carcinoma.
Sload R; Silver N; Jawad BA; Gross ND
Curr Oncol Rep; 2016 Sep; 18(9):53. PubMed ID: 27469262
[TBL] [Abstract][Full Text] [Related]
20. Occult contralateral nodal disease in oropharyngeal squamous cell carcinoma patients undergoing primary TORS with bilateral neck dissection.
McMullen CP; Garneau J; Weimar E; Ali S; Farinhas JM; Yu E; Som PM; Sarta C; Goldstein DP; Su S; Xu W; Smith RV; Miles B; de Almeida JR
Oral Oncol; 2019 Jun; 93():96-100. PubMed ID: 31109703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
